Sign up to our newsletter Subscribe

All Topics
Health Technology Assessment (HTA)
Antimicrobial Resistance (AMR)

Newsletter SignupSubscribe

Search publications, topics, authors and more

Sign up to our newsletter Subscribe

All Topics
Health Technology Assessment (HTA)
Antimicrobial Resistance (AMR)

Newsletter SignupSubscribe

Search publications, topics, authors and more

Close

Research & Publications
News & Insights
Education
Innovation Policy Prize

Events
About Us
OHE Experts
Join OHE
Contact Us

Newsletter SignupSubscribe

Research & Publications

All Publications

Filter by:

Antimicrobial Resistance (AMR)
Biosimilars
Cell and Gene Therapies
Chronic Diseases
Combination Therapies
COVID-19 Research
Digital Health
Drug Development/R&D
Emerging Markets
EQ-5D and PROMs
Indication-Based Pricing
Health Care Systems
Health Data and Statistics
Health Technology Assessment
Precision Medicine
Prevention
Real-World Evidence
Sustainability
Use of Medicines
Value-Based Pricing
Vaccine Research

Economics of Innovation
Measuring and Valuing Outcomes
Policy, Organisation and Incentives in Health Systems
Value, Affordability and Decision Making

News & Insights

News
Events
Insights
Bulletin

Education

Education Hub
OHE Graduate School
EVIA Programme

Innovation Policy Prize

The Prize Fund
2024 Prize Fund
2022 Prize Fund

Search publications, topics, authors and more

Latest Research & Publications

Health Care Systems
Economics of Innovation
Market Access

International Comparison of Medicines Usage: Quantitative Analysis from a Swedish Perspective

Read more

Emerging Markets
Measuring and Valuing Outcomes
Health Policy and Regulation

International Decision Support Initiative (iDSI): Mapping of priority-setting in health in 17 low and middle countries across Asia, Latin America, and Africa

Read more

Combination Therapies
Economics of Innovation
Health Policy and Regulation

Assessing the Use of Multi-indication Medicines: A Review of Current Data Capabilities in the UK

Read more

Health Technology Assessment…
Value, Affordability, and…

A Framework for Payer Assessment of the Value of New Technologies: A US Approach

Read more

Health Care Systems
Policy, Organisation and…
Quality of Care

Incentives to follow Best Practice in Health Care

Read more

Measuring and Valuing Outcomes
Clinical Outcomes

An Investigation of the Feasibility and Cultural Appropriateness of Stated Preference Methods to Generate EQ-5D-5L Values in the United Arab Emirates

Read more

Value, Affordability, and…
Clinical Outcomes

Do Respondents Completing Abstract, Hypothetical Priority-setting Exercises Agree With the Policy Implications of Their Choices?

Read more

Emerging Markets

Universal Health Coverage: The Holy Grail?

Read more

00
19
20
21
22
23
24
25
26
27
00

Close

All Publications

Filter by:

Antimicrobial Resistance (AMR)

Biosimilars

Cell and Gene Therapies

Chronic Diseases

Combination Therapies

COVID-19 Research

Digital Health

Drug Development/R&D

Emerging Markets

EQ-5D and PROMs

Indication-Based Pricing

Health Care Systems

Health Data and Statistics

Health Technology Assessment

Precision Medicine

Prevention

Real-World Evidence

Sustainability

Use of Medicines

Value-Based Pricing

Vaccine Research

Economics of Innovation

Measuring and Valuing Outcomes

Policy, Organisation and Incentives in Health Systems

Value, Affordability and Decision Making
News

Events

Insights

Bulletin
Education Hub

OHE Graduate School

EVIA Programme
The Prize Fund

2024 Prize Fund

2022 Prize Fund

Events
About Us
OHE Experts
Join OHE
Contact Us

Newsletter SignupSubscribe

Drug Development Process and R&D

New medicines lead to improved patient outcomes and societal benefits, but R&D is a long and costly process. Ongoing health economics research aims to find the right balance between incentivising manufacturers to innovate and ensuring affordable access for health systems.

Filter results by

Theme

Select the product option you would like to filter Theme

Economics of Innovation Measuring and Valuing Outcomes Policy, Organisation and Incentives in Health Systems Value, Affordability, and Decision Making

Tag

Select the product option you would like to filter Tag

Adult Immunisation Alzheimer's Broader value and societal perspective in HTA Budget Impact Analysis Cancer Cardiovascular Disorders Care-givers Caring burden Cervical Cancer Clinical Outcomes Commentary Competition Dermatology Determining Value Diversity of Supply Drug Shortages Economic Evaluation Egypt Epidemiology and Public Health Epilepsy Gene therapies Generics Greece Haemophilia Health Policy and Regulation Health System Resiliency Healthcare Delivery Healthcare Expenditure Healthcare Funding Healthcare System Pressure (HCSP) India Infectious Diseases Inflation Reduction Act Injury and Trauma Innovation Israel Market Access Mental Health Pharmaceutical Industry Plant-based Policy Analysis Pricing and Reimbursement Primary Care Quality of Care Quality of Life Rare and Orphan Diseases Research Funding Resource Allocation Respiratory Cost Calculator Saudi Arabia Slovak Republic Societal preferences Supply of Medicine Türkiye Unmet Need Vaccines Value based pricing Webinar

Date 1

Select the product option you would like to filter Date

Date From

Month From

Year From

Date To

Month To

Year To

Author

Select the product option you would like to filter Author

Search authors

Neil Mcauslane Adam Raymakers Kiran Bhatti Kelsey Moore Meindert Boysen Pedro Pita Barros Andrew Briggs Thomas Pogge Antonella Cardone Stan Jackson

Content Type

Select the product option you would like to filter Content Type

news story insight events podcast bulletin publications

Featured

Past Event
Commissioned Webinar
September 2024

Drug Shortages: What are the causes, consequences and pathways to a solution?

A close-up image of a collection of orange prescription bottles neatly aligned in rows, with white caps and blank labels, against a white background. The repetitive pattern and bright color highlight the pharmaceutical industry’s mass production of medication.

Insight
September 2024

Drug shortages are on the rise – but what is their impact?

Filter results by

Theme

Select the product option you would like to filter Theme

Economics of Innovation Measuring and Valuing Outcomes Policy, Organisation and Incentives in Health Systems Value, Affordability, and Decision Making

Tag

Select the product option you would like to filter Tag

Adult Immunisation Alzheimer's Broader value and societal perspective in HTA Budget Impact Analysis Cancer Cardiovascular Disorders Care-givers Caring burden Cervical Cancer Clinical Outcomes Commentary Competition Dermatology Determining Value Diversity of Supply Drug Shortages Economic Evaluation Egypt Epidemiology and Public Health Epilepsy Gene therapies Generics Greece Haemophilia Health Policy and Regulation Health System Resiliency Healthcare Delivery Healthcare Expenditure Healthcare Funding Healthcare System Pressure (HCSP) India Infectious Diseases Inflation Reduction Act Injury and Trauma Innovation Israel Market Access Mental Health Pharmaceutical Industry Plant-based Policy Analysis Pricing and Reimbursement Primary Care Quality of Care Quality of Life Rare and Orphan Diseases Research Funding Resource Allocation Respiratory Cost Calculator Saudi Arabia Slovak Republic Societal preferences Supply of Medicine Türkiye Unmet Need Vaccines Value based pricing Webinar

Date 1

Select the product option you would like to filter Date

Date From

Month From

Year From

Date To

Month To

Year To

Author

Select the product option you would like to filter Author

Search authors

Neil Mcauslane Adam Raymakers Kiran Bhatti Kelsey Moore Meindert Boysen Pedro Pita Barros Andrew Briggs Thomas Pogge Antonella Cardone Stan Jackson

Content Type

Select the product option you would like to filter Content Type

news story insight events podcast bulletin publications

No posts found

Leading intellectual authority on global health economics

Sign Up for OHE Insights, Events & News Bulletin

Newsletter SignupStart Sign Up

Research & Publications

News & Insights

Innovation Policy Prize

Sign Up for OHE Insights, Events & News Bulletin

Newsletter SignupStart Sign Up

The Office of Health Economics (OHE) is a company limited by guarantee registered in England and Wales (registered number 09848965) and its registered office is at 2nd Floor Goldings House, Hay’s Galleria, 2 Hay’s Lane, London, SE1 2HB.

Terms & Conditions

© 2025 Website Design

An error has occurred, please try again later.

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in .

Share on Mastodon

Enter your Mastodon instance URL (optional)

Powered by GDPR Cookie Compliance

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

Enable or Disable Cookies Enabled Disabled

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.

3rd Party Cookies

This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

Keeping this cookie enabled helps us to improve our website.

Enable or Disable Cookies Enabled Disabled

Please enable Strictly Necessary Cookies first so that we can save your preferences!